HEADER OXIDOREDUCTASE 16-NOV-18 6I79
TITLE SEPIAPTERIN REDUCTASE IN COMPLEX WITH COMPOUND 4
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: SEPIAPTERIN REDUCTASE;
COMPND 3 CHAIN: A, B;
COMPND 4 SYNONYM: SPR;
COMPND 5 EC: 1.1.1.153;
COMPND 6 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: SPR;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3);
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008;
SOURCE 8 EXPRESSION_SYSTEM_VARIANT: NICO;
SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET28
KEYWDS SEPIAPTERIN-REDUCTASE, OXIDOREDUCTASE, PROTEROS BIOSTRUCTURES GMBH
EXPDTA X-RAY DIFFRACTION
AUTHOR J.ALEN,M.SCHADE,M.WAGENER,M.BLAESSE
REVDAT 3 15-MAY-24 6I79 1 REMARK
REVDAT 2 24-JUL-19 6I79 1 JRNL
REVDAT 1 10-JUL-19 6I79 0
JRNL AUTH J.ALEN,M.SCHADE,M.WAGENER,F.CHRISTIAN,S.NORDHOFF,B.MERLA,
JRNL AUTH 2 T.R.DUNKERN,G.BAHRENBERG,P.RATCLIFFE
JRNL TITL FRAGMENT-BASED DISCOVERY OF NOVEL POTENT SEPIAPTERIN
JRNL TITL 2 REDUCTASE INHIBITORS.
JRNL REF J.MED.CHEM. V. 62 6391 2019
JRNL REFN ISSN 0022-2623
JRNL PMID 31244106
JRNL DOI 10.1021/ACS.JMEDCHEM.9B00218
REMARK 2
REMARK 2 RESOLUTION. 1.63 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : REFMAC 5.8.0155
REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,
REMARK 3 : NICHOLLS,WINN,LONG,VAGIN
REMARK 3
REMARK 3 REFINEMENT TARGET : NULL
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.63
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 54.85
REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL
REMARK 3 COMPLETENESS FOR RANGE (%) : 95.4
REMARK 3 NUMBER OF REFLECTIONS : 56164
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.166
REMARK 3 R VALUE (WORKING SET) : 0.162
REMARK 3 FREE R VALUE : 0.217
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.800
REMARK 3 FREE R VALUE TEST SET COUNT : 3459
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 20
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.63
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.67
REMARK 3 REFLECTION IN BIN (WORKING SET) : 3033
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 69.43
REMARK 3 BIN R VALUE (WORKING SET) : 0.3840
REMARK 3 BIN FREE R VALUE SET COUNT : 203
REMARK 3 BIN FREE R VALUE : 0.4320
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 4114
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 134
REMARK 3 SOLVENT ATOMS : 254
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.36
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : 2.00000
REMARK 3 B22 (A**2) : -0.57000
REMARK 3 B33 (A**2) : -1.26000
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : -0.77000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED OVERALL COORDINATE ERROR.
REMARK 3 ESU BASED ON R VALUE (A): 0.146
REMARK 3 ESU BASED ON FREE R VALUE (A): 0.103
REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.090
REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.469
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.975
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.957
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT
REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4309 ; 0.010 ; 0.019
REMARK 3 BOND LENGTHS OTHERS (A): 4175 ; 0.002 ; 0.020
REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5871 ; 1.562 ; 2.033
REMARK 3 BOND ANGLES OTHERS (DEGREES): 9573 ; 1.411 ; 3.000
REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 548 ; 6.045 ; 5.000
REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 169 ;36.810 ;24.083
REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 713 ;10.686 ;15.000
REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 31 ;18.000 ;15.000
REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 671 ; 0.076 ; 0.200
REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4889 ; 0.005 ; 0.021
REMARK 3 GENERAL PLANES OTHERS (A): 948 ; 0.002 ; 0.020
REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2186 ; 3.088 ; 3.862
REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2185 ; 3.052 ; 3.861
REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2736 ; 3.413 ; 6.513
REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2737 ; 3.433 ; 6.514
REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2123 ; 3.557 ; 4.386
REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 2123 ; 3.557 ; 4.386
REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 3130 ; 3.689 ; 7.138
REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 4602 ; 3.861 ;35.926
REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 4603 ; 3.860 ;35.927
REMARK 3
REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 RIGID-BOND RESTRAINTS (A**2): 8484 ; 6.990 ; 3.000
REMARK 3 SPHERICITY; FREE ATOMS (A**2): 142 ;18.723 ; 5.000
REMARK 3 SPHERICITY; BONDED ATOMS (A**2): 8516 ; 6.863 ; 5.000
REMARK 3
REMARK 3 NCS RESTRAINTS STATISTICS
REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : NULL
REMARK 3 PARAMETERS FOR MASK CALCULATION
REMARK 3 VDW PROBE RADIUS : 1.20
REMARK 3 ION PROBE RADIUS : 0.80
REMARK 3 SHRINKAGE RADIUS : 0.80
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING
REMARK 3 POSITIONS
REMARK 4
REMARK 4 6I79 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 16-NOV-18.
REMARK 100 THE DEPOSITION ID IS D_1200012923.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 07-APR-17
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : NULL
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : SLS
REMARK 200 BEAMLINE : X06SA
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.99999
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : PIXEL
REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS
REMARK 200 DATA SCALING SOFTWARE : XSCALE
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 59623
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.630
REMARK 200 RESOLUTION RANGE LOW (A) : 54.850
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 95.4
REMARK 200 DATA REDUNDANCY : 3.800
REMARK 200 R MERGE (I) : 0.04200
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 16.7800
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.63
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.88
REMARK 200 COMPLETENESS FOR SHELL (%) : 87.1
REMARK 200 DATA REDUNDANCY IN SHELL : 3.20
REMARK 200 R MERGE FOR SHELL (I) : 0.60100
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: REFMAC
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 41.29
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.09
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 15.00 %W/V PEG 3350, 0.50 M MG
REMARK 280 FORMATE, VAPOR DIFFUSION, TEMPERATURE 293.15K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 49.74800
REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 6280 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 22540 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -44.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 MET A -14
REMARK 465 GLY A -13
REMARK 465 HIS A -12
REMARK 465 HIS A -11
REMARK 465 HIS A -10
REMARK 465 MET B -14
REMARK 465 GLY B -13
REMARK 465 HIS B -12
REMARK 465 HIS B -11
REMARK 465 HIS B -10
REMARK 480
REMARK 480 ZERO OCCUPANCY ATOM
REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO
REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS
REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME;
REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE):
REMARK 480 M RES C SSEQI ATOMS
REMARK 480 GLU A 2 CD OE1 OE2
REMARK 480 GLN A 78 CD OE1 NE2
REMARK 480 LEU A 83 CD1 CD2
REMARK 480 LYS A 90 CD CE NZ
REMARK 480 LYS A 140 CE NZ
REMARK 480 LYS A 220 CD CE NZ
REMARK 480 GLU A 246 CD OE1 OE2
REMARK 480 LYS A 247 NZ
REMARK 480 GLU A 249 CD OE1 OE2
REMARK 480 LYS A 261 CD CE NZ
REMARK 480 GLU B 2 CG CD OE1 OE2
REMARK 480 GLU B 57 CG CD OE1 OE2
REMARK 480 ARG B 58 CG CD NE CZ NH1 NH2
REMARK 480 LYS B 235 CD CE NZ
REMARK 480 LYS B 247 CE NZ
REMARK 480 LYS B 261 CG CD CE NZ
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ALA A 41 163.82 166.38
REMARK 500 PHE A 142 79.17 -115.17
REMARK 500
REMARK 500 REMARK: NULL
REMARK 525
REMARK 525 SOLVENT
REMARK 525
REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT
REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST
REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT
REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE
REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER;
REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE
REMARK 525 NUMBER; I=INSERTION CODE):
REMARK 525
REMARK 525 M RES CSSEQI
REMARK 525 HOH B 527 DISTANCE = 6.39 ANGSTROMS
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue NAP A 301
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue H5E A 302
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue NAP B 301
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue H5E B 302
DBREF 6I79 A 1 261 UNP P35270 SPRE_HUMAN 1 261
DBREF 6I79 B 1 261 UNP P35270 SPRE_HUMAN 1 261
SEQADV 6I79 MET A -14 UNP P35270 INITIATING METHIONINE
SEQADV 6I79 GLY A -13 UNP P35270 EXPRESSION TAG
SEQADV 6I79 HIS A -12 UNP P35270 EXPRESSION TAG
SEQADV 6I79 HIS A -11 UNP P35270 EXPRESSION TAG
SEQADV 6I79 HIS A -10 UNP P35270 EXPRESSION TAG
SEQADV 6I79 HIS A -9 UNP P35270 EXPRESSION TAG
SEQADV 6I79 HIS A -8 UNP P35270 EXPRESSION TAG
SEQADV 6I79 HIS A -7 UNP P35270 EXPRESSION TAG
SEQADV 6I79 GLU A -6 UNP P35270 EXPRESSION TAG
SEQADV 6I79 ASN A -5 UNP P35270 EXPRESSION TAG
SEQADV 6I79 LEU A -4 UNP P35270 EXPRESSION TAG
SEQADV 6I79 TYR A -3 UNP P35270 EXPRESSION TAG
SEQADV 6I79 PHE A -2 UNP P35270 EXPRESSION TAG
SEQADV 6I79 GLN A -1 UNP P35270 EXPRESSION TAG
SEQADV 6I79 GLY A 0 UNP P35270 EXPRESSION TAG
SEQADV 6I79 MET B -14 UNP P35270 INITIATING METHIONINE
SEQADV 6I79 GLY B -13 UNP P35270 EXPRESSION TAG
SEQADV 6I79 HIS B -12 UNP P35270 EXPRESSION TAG
SEQADV 6I79 HIS B -11 UNP P35270 EXPRESSION TAG
SEQADV 6I79 HIS B -10 UNP P35270 EXPRESSION TAG
SEQADV 6I79 HIS B -9 UNP P35270 EXPRESSION TAG
SEQADV 6I79 HIS B -8 UNP P35270 EXPRESSION TAG
SEQADV 6I79 HIS B -7 UNP P35270 EXPRESSION TAG
SEQADV 6I79 GLU B -6 UNP P35270 EXPRESSION TAG
SEQADV 6I79 ASN B -5 UNP P35270 EXPRESSION TAG
SEQADV 6I79 LEU B -4 UNP P35270 EXPRESSION TAG
SEQADV 6I79 TYR B -3 UNP P35270 EXPRESSION TAG
SEQADV 6I79 PHE B -2 UNP P35270 EXPRESSION TAG
SEQADV 6I79 GLN B -1 UNP P35270 EXPRESSION TAG
SEQADV 6I79 GLY B 0 UNP P35270 EXPRESSION TAG
SEQRES 1 A 276 MET GLY HIS HIS HIS HIS HIS HIS GLU ASN LEU TYR PHE
SEQRES 2 A 276 GLN GLY MET GLU GLY GLY LEU GLY ARG ALA VAL CYS LEU
SEQRES 3 A 276 LEU THR GLY ALA SER ARG GLY PHE GLY ARG THR LEU ALA
SEQRES 4 A 276 PRO LEU LEU ALA SER LEU LEU SER PRO GLY SER VAL LEU
SEQRES 5 A 276 VAL LEU SER ALA ARG ASN ASP GLU ALA LEU ARG GLN LEU
SEQRES 6 A 276 GLU ALA GLU LEU GLY ALA GLU ARG SER GLY LEU ARG VAL
SEQRES 7 A 276 VAL ARG VAL PRO ALA ASP LEU GLY ALA GLU ALA GLY LEU
SEQRES 8 A 276 GLN GLN LEU LEU GLY ALA LEU ARG GLU LEU PRO ARG PRO
SEQRES 9 A 276 LYS GLY LEU GLN ARG LEU LEU LEU ILE ASN ASN ALA GLY
SEQRES 10 A 276 SER LEU GLY ASP VAL SER LYS GLY PHE VAL ASP LEU SER
SEQRES 11 A 276 ASP SER THR GLN VAL ASN ASN TYR TRP ALA LEU ASN LEU
SEQRES 12 A 276 THR SER MET LEU CYS LEU THR SER SER VAL LEU LYS ALA
SEQRES 13 A 276 PHE PRO ASP SER PRO GLY LEU ASN ARG THR VAL VAL ASN
SEQRES 14 A 276 ILE SER SER LEU CYS ALA LEU GLN PRO PHE LYS GLY TRP
SEQRES 15 A 276 ALA LEU TYR CYS ALA GLY LYS ALA ALA ARG ASP MET LEU
SEQRES 16 A 276 PHE GLN VAL LEU ALA LEU GLU GLU PRO ASN VAL ARG VAL
SEQRES 17 A 276 LEU ASN TYR ALA PRO GLY PRO LEU ASP THR ASP MET GLN
SEQRES 18 A 276 GLN LEU ALA ARG GLU THR SER VAL ASP PRO ASP MET ARG
SEQRES 19 A 276 LYS GLY LEU GLN GLU LEU LYS ALA LYS GLY LYS LEU VAL
SEQRES 20 A 276 ASP CYS LYS VAL SER ALA GLN LYS LEU LEU SER LEU LEU
SEQRES 21 A 276 GLU LYS ASP GLU PHE LYS SER GLY ALA HIS VAL ASP PHE
SEQRES 22 A 276 TYR ASP LYS
SEQRES 1 B 276 MET GLY HIS HIS HIS HIS HIS HIS GLU ASN LEU TYR PHE
SEQRES 2 B 276 GLN GLY MET GLU GLY GLY LEU GLY ARG ALA VAL CYS LEU
SEQRES 3 B 276 LEU THR GLY ALA SER ARG GLY PHE GLY ARG THR LEU ALA
SEQRES 4 B 276 PRO LEU LEU ALA SER LEU LEU SER PRO GLY SER VAL LEU
SEQRES 5 B 276 VAL LEU SER ALA ARG ASN ASP GLU ALA LEU ARG GLN LEU
SEQRES 6 B 276 GLU ALA GLU LEU GLY ALA GLU ARG SER GLY LEU ARG VAL
SEQRES 7 B 276 VAL ARG VAL PRO ALA ASP LEU GLY ALA GLU ALA GLY LEU
SEQRES 8 B 276 GLN GLN LEU LEU GLY ALA LEU ARG GLU LEU PRO ARG PRO
SEQRES 9 B 276 LYS GLY LEU GLN ARG LEU LEU LEU ILE ASN ASN ALA GLY
SEQRES 10 B 276 SER LEU GLY ASP VAL SER LYS GLY PHE VAL ASP LEU SER
SEQRES 11 B 276 ASP SER THR GLN VAL ASN ASN TYR TRP ALA LEU ASN LEU
SEQRES 12 B 276 THR SER MET LEU CYS LEU THR SER SER VAL LEU LYS ALA
SEQRES 13 B 276 PHE PRO ASP SER PRO GLY LEU ASN ARG THR VAL VAL ASN
SEQRES 14 B 276 ILE SER SER LEU CYS ALA LEU GLN PRO PHE LYS GLY TRP
SEQRES 15 B 276 ALA LEU TYR CYS ALA GLY LYS ALA ALA ARG ASP MET LEU
SEQRES 16 B 276 PHE GLN VAL LEU ALA LEU GLU GLU PRO ASN VAL ARG VAL
SEQRES 17 B 276 LEU ASN TYR ALA PRO GLY PRO LEU ASP THR ASP MET GLN
SEQRES 18 B 276 GLN LEU ALA ARG GLU THR SER VAL ASP PRO ASP MET ARG
SEQRES 19 B 276 LYS GLY LEU GLN GLU LEU LYS ALA LYS GLY LYS LEU VAL
SEQRES 20 B 276 ASP CYS LYS VAL SER ALA GLN LYS LEU LEU SER LEU LEU
SEQRES 21 B 276 GLU LYS ASP GLU PHE LYS SER GLY ALA HIS VAL ASP PHE
SEQRES 22 B 276 TYR ASP LYS
HET NAP A 301 48
HET H5E A 302 19
HET NAP B 301 48
HET H5E B 302 19
HETNAM NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE
HETNAM H5E 6-[(4-~{TERT}-BUTYL-1,3-THIAZOL-2-YL)METHYL]-4,6-
HETNAM 2 H5E DIAZASPIRO[2.4]HEPTANE-5,7-DIONE
HETSYN NAP 2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE
FORMUL 3 NAP 2(C21 H28 N7 O17 P3)
FORMUL 4 H5E 2(C13 H17 N3 O2 S)
FORMUL 7 HOH *254(H2 O)
HELIX 1 AA1 HIS A -9 GLY A 0 1 10
HELIX 2 AA2 ARG A 17 LEU A 30 1 14
HELIX 3 AA3 ASN A 43 GLY A 55 1 13
HELIX 4 AA4 ALA A 72 GLU A 85 1 14
HELIX 5 AA5 GLY A 110 LEU A 114 5 5
HELIX 6 AA6 ASP A 116 LEU A 128 1 13
HELIX 7 AA7 LEU A 128 PHE A 142 1 15
HELIX 8 AA8 SER A 157 LEU A 161 5 5
HELIX 9 AA9 TRP A 167 GLU A 188 1 22
HELIX 10 AB1 THR A 203 SER A 213 1 11
HELIX 11 AB2 ASP A 215 LYS A 228 1 14
HELIX 12 AB3 ASP A 233 ASP A 248 1 16
HELIX 13 AB4 HIS B -8 GLY B 0 1 9
HELIX 14 AB5 ARG B 17 LEU B 30 1 14
HELIX 15 AB6 ASN B 43 ARG B 58 1 16
HELIX 16 AB7 ALA B 72 GLU B 85 1 14
HELIX 17 AB8 GLY B 110 LEU B 114 5 5
HELIX 18 AB9 ASP B 116 LEU B 128 1 13
HELIX 19 AC1 LEU B 128 PHE B 142 1 15
HELIX 20 AC2 SER B 157 LEU B 161 5 5
HELIX 21 AC3 TRP B 167 GLU B 188 1 22
HELIX 22 AC4 THR B 203 SER B 213 1 11
HELIX 23 AC5 ASP B 215 LYS B 228 1 14
HELIX 24 AC6 ASP B 233 ASP B 248 1 16
SHEET 1 AA1 7 ARG A 62 PRO A 67 0
SHEET 2 AA1 7 VAL A 36 ALA A 41 1 N LEU A 37 O ARG A 62
SHEET 3 AA1 7 ALA A 8 LEU A 12 1 N CYS A 10 O VAL A 38
SHEET 4 AA1 7 ARG A 94 ASN A 99 1 O ILE A 98 N LEU A 11
SHEET 5 AA1 7 ASN A 149 ILE A 155 1 O THR A 151 N LEU A 95
SHEET 6 AA1 7 ARG A 192 ALA A 197 1 O LEU A 194 N ASN A 154
SHEET 7 AA1 7 ALA A 254 ASP A 257 1 O VAL A 256 N ASN A 195
SHEET 1 AA2 7 ARG B 62 PRO B 67 0
SHEET 2 AA2 7 VAL B 36 ALA B 41 1 N LEU B 39 O VAL B 64
SHEET 3 AA2 7 ALA B 8 THR B 13 1 N CYS B 10 O VAL B 38
SHEET 4 AA2 7 ARG B 94 ASN B 99 1 O ILE B 98 N LEU B 11
SHEET 5 AA2 7 ASN B 149 ILE B 155 1 O VAL B 153 N ASN B 99
SHEET 6 AA2 7 ARG B 192 ALA B 197 1 O ARG B 192 N ARG B 150
SHEET 7 AA2 7 ALA B 254 ASP B 257 1 O VAL B 256 N ASN B 195
SITE 1 AC1 33 GLY A 14 SER A 16 ARG A 17 GLY A 18
SITE 2 AC1 33 PHE A 19 ALA A 41 ARG A 42 ASN A 43
SITE 3 AC1 33 ALA A 68 ASP A 69 LEU A 70 ASN A 100
SITE 4 AC1 33 ALA A 101 GLY A 102 LEU A 126 ILE A 155
SITE 5 AC1 33 SER A 156 TYR A 170 LYS A 174 PRO A 198
SITE 6 AC1 33 GLY A 199 PRO A 200 LEU A 201 THR A 203
SITE 7 AC1 33 MET A 205 H5E A 302 HOH A 403 HOH A 409
SITE 8 AC1 33 HOH A 452 HOH A 465 HOH A 478 HOH A 480
SITE 9 AC1 33 HOH A 481
SITE 1 AC2 9 LEU A 104 SER A 157 CYS A 159 TRP A 167
SITE 2 AC2 9 TYR A 170 MET A 205 GLN A 206 NAP A 301
SITE 3 AC2 9 HOH A 494
SITE 1 AC3 33 GLY B 14 SER B 16 ARG B 17 GLY B 18
SITE 2 AC3 33 PHE B 19 ALA B 41 ARG B 42 ASN B 43
SITE 3 AC3 33 ALA B 68 ASP B 69 LEU B 70 ASN B 100
SITE 4 AC3 33 ALA B 101 GLY B 102 LEU B 126 ILE B 155
SITE 5 AC3 33 SER B 156 TYR B 170 LYS B 174 PRO B 198
SITE 6 AC3 33 GLY B 199 PRO B 200 LEU B 201 THR B 203
SITE 7 AC3 33 MET B 205 GLN B 206 H5E B 302 HOH B 405
SITE 8 AC3 33 HOH B 437 HOH B 441 HOH B 444 HOH B 451
SITE 9 AC3 33 HOH B 473
SITE 1 AC4 10 LEU B 104 SER B 157 CYS B 159 TRP B 167
SITE 2 AC4 10 TYR B 170 MET B 205 GLN B 206 MET B 218
SITE 3 AC4 10 NAP B 301 HOH B 479
CRYST1 46.783 99.496 55.109 90.00 95.51 90.00 P 1 21 1 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.021375 0.000000 0.002063 0.00000
SCALE2 0.000000 0.010051 0.000000 0.00000
SCALE3 0.000000 0.000000 0.018230 0.00000